MedTech - 17 Dec 24

Weekly Med Tech News post by Abnormal Docs

🎓 Scholarships/Internships

• NIG Internship 2025 Japan is receiving applications for biotech research

  

• The International Journal of Medical Students (IJMS) invites applications for its 2025 Editorial Team!

---

🆕 New Approval

• FDA panel seeks more data on RSV vaccine safety in infants: FDA has partially paused testing

• FDA flags additional injury risk for Intercept’s liver drug

• FDA has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for a type of lung cancer

  ---

🤖 AI & ML

Karl Storz announced the U.S. launch of Pathway.AI, a new operating room tool offered in partnership with Artisight to increase OR efficiency

---

🌎 World

Democratic Republic of Congo's health ministry said on Tuesday that a previously unidentified disease circulating in the country's Panzi health zone is a severe form of malaria.

🇮🇳 India

• Mumps Outbreak In Kerala: Over 50 New Cases Reported Daily In Thiruvananthapuram; Officials Issue Warning

• The health department distributed Morbidity Management and Disability Prevention .(MMDP) kits to more than 50 filariasis patients.

🎓 Education

‘Getting paid to review is justice’: journal pays peer reviewers in cryptocurrency

💊 Pharma & Market

• Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and Crohn's disease showed it had met primary goals

• Merck said on Monday it has discontinued the development of two experimental cancer drugs - vibostolimab and favezelima, after their failure in several trials.

🔍 Research

Abbott completes first-in-human leadless left bundle branch area pacing procedures

🩺 Medical Devices

The Low-Cost, Battery-Powered AI-Enabled Ultrasound Device That Could Improve Global Obstetric Care

SS Innovations Surgical Robot system gets CDSCO approval

🎯 Opportunities

Want to join our team? 👉🏻 Click here

Follow us on

1. Twitter

2. Instagram

3. LinkedIn

4. WhatsApp channel